Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Arginase-1 (D4E3M™) XP® Rabbit mAb (HRP Conjugate)


Cell Signalling Technology logo
View Antibody details

Arginase-2 (D9J1N) XP® Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Argonaute 1 (D84G10) XP® Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Argonaute 2 (C34C6) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Argonaute 3 (D15D2) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Argonaute 4 (D10F10) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

ARID1A/BAF250A (D2A8U) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

ARID1B/BAF250B (E1U7D) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

ARID1B/BAF250B (E9J4T) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

ARID2 (D8D8U) Rabbit mAb


Cell Signalling Technology logo
View Antibody details